US 8692052
Genetically modified mice and engraftment
granted A61KA61K49/00
Quick answer
US patent 8692052 (Genetically modified mice and engraftment) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K49/00